Mayo Clinic joins call for increased screening for HPV-related cancers
(Mayo Clinic) Mayo Clinic Cancer Center joined 69 other National Cancer Institute-designated cancer centers in calling for increased HPV vaccination and screening to eliminate HPV-related cancers. Participating centers issued a joint statement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2018 Category: International Medicine & Public Health Source Type: news

Malaria: Cooperating antibodies enhance immune response
In this study, the researchers discovered a previously unnoticed characteristic of antibodies against the malaria parasite: They can cooperate with each other, thus binding even stronger to the pathogens and improving the immune response. The results, now published in Science, are expected to help develop a more effective vaccine against the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 7, 2018 Category: Infectious Diseases Source Type: news

Mayo Clinic joins call for increased screening for HPV-related cancers
ROCHESTER, Minn. ? Mayo Clinic Cancer Center joined 69 other National Cancer Institute-designated cancer centers in calling for increased HPV vaccination and screening to eliminate HPV-related cancers. Participating centers issued a joint statement. According to the statement, nearly 80 million Americans ? 1 out of every 4 people ? are infected with HPV, and more [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 7, 2018 Category: Databases & Libraries Source Type: news

Medical News Today: Vaginal bacteria may have a role in cervical cancer
A new study reveals that microbe composition and other conditions in the vagina are linked to the development of cervical cancer in all its stages. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 6, 2018 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

A Biotech Executive Faces End-Stage Cancer As A Patient
Michael Becker used to be a biotech CEO. Now he wants people know about HPV, the vaccine-preventable virus that caused the cancer that spread from his throat into his lungs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 6, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Source Type: news

Personalized vaccine may increase long-term survival in people with deadliest form of brain cancer
An international study led by UCLA researchers has found that a personalized vaccine may help people with glioblastoma, the deadliest form of brain cancer, live longer. The vaccine, known as DCVax-L, uses a person ’s own white blood cells to help activate the immune system to fight cancer.Nearly 30 percent of people in the ongoing trial have survived for at least three years after they enrolled in the study. Currently, the average life expectancy for people diagnosed with glioblastoma is 15 to 17 months, and less than 5 percent of people who receive standard treatment survive more than five years after they are diagn...
Source: UCLA Newsroom: Health Sciences - June 5, 2018 Category: Universities & Medical Training Source Type: news

Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
An international Phase III study led by researchers at UCLA and at Northwest Biotherapeutics, Inc. has found that a personalized glioblastoma vaccine may increase long-term survival in some patients. Nearly 30 percent of patients in the current trial have now survived at least three years post-enrollment, with patients continuing to be followed over time. (Source: World Pharma News)
Source: World Pharma News - June 4, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
(University of California - Los Angeles Health Sciences) An international Phase III study led by researchers at UCLA has found that a personalized GBM vaccine may increase long-term survival in some patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

Wayne State professor receives NSF CAREER award for vaccine adjuvant research
(Wayne State University - Office of the Vice President for Research) Haipeng Liu, Ph.D., assistant professor of chemical engineering at Wayne State University, received a Faculty Early Career Development (CAREER) award from the National Science Foundation to fund his research on vaccine adjuvants that can improve the treatment and care of cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

A great majority of Mozambican adolescent girls are willing to be vaccinated against HPV
(Barcelona Institute for Global Health (ISGlobal)) A study in Mozambique reveals that a majority of adolescent girls interviewed would be willing to get vaccinated against Human Papilloma Virus (HPV) if the vaccine was available in the country. These results are encouraging with regard to vaccine introduction and reducing mortality associated with cervical cancer in Mozambique. The investigation was led by the Manhi ç a Health Research Center (CISM) and ISGlobal, an institution supported by " la Caixa " Foundation (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

Anti-HPV jab will be given to teenage boys if they identify as girls
The NHS will give a lifesaving cancer vaccine to teenage boys in the UK – but only if they ‘identify’ as girls. Taking the Gardasil jab will help them fit in with 'their peers', it is claimed. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2018 Category: Consumer Health News Source Type: news

Glioblastoma Brain Cancer Vaccine Effective in Some Patients
Multicenter clinical trial of personalized vaccine that targets glioblastoma brain cancer has indicated improved survival rates for patients (Source: Disabled World)
Source: Disabled World - June 1, 2018 Category: Disability Tags: Brain Cancers Source Type: news

Cleveland Clinic Cancer Center experts present data at 2018 ASCO Annual Meeting
(Cleveland Clinic) At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, researchers from Cleveland Clinic Cancer Center will present data from several new studies, including a prospective clinical trial examining non-small cell lung cancer cells' response to immunotherapy; research on germline testing for melanoma; and interim results from a study testing a vaccine for glioblastoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 1, 2018 Category: International Medicine & Public Health Source Type: news

Uganda:Women Shun HPV Vaccine
[Monitor] Kampala -Women and girls in Uganda have continued to shun the Human Papilloma Vaccine (HPV) meant to protect them against cervical cancer, a new study has shown. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 31, 2018 Category: African Health Source Type: news

New report and resources put cancer in context, showing more than 1,100 medicines and vaccines in development
In the not too distant past, chemotherapy and radiation were once the only treatments for what remains the second leading cause of death in the United States – cancer. Although the death rates of cancer have declined in the past 20 years and survival rates have increased by five times since the 1970s, there is still more work to be done. The biopharmaceutical industry is leading by translating science into a completely new era of medicine for how we treat the diseases which make up cancer. (Source: The Catalyst)
Source: The Catalyst - May 30, 2018 Category: Pharmaceuticals Tags: Medicines in Development Research and Development cancer New Era of Medicine Source Type: news

Doctors Can Increase Vaccination Rates In Kids Using New Approach, Study Finds
Persistence and a unified, targeted approach can pay off for doctors when parents are reluctant to vaccinate their children against HPV, the human papilloma virus, a cause of anogenital, mouth, throat and cervical cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 30, 2018 Category: Pharmaceuticals Authors: Robert Glatter, MD, Contributor Source Type: news

Brain cancer vaccine could extend lives of patients by years
Trial on people with form of disease that killed Tessa Jowell ‘remarkably promising’A vaccine could add years to the lives of people with the aggressive form of brain cancer that killed theformer Labour cabinet minister Tessa Jowell, trials suggest.The treatment for people with glioblastoma works by using the immune cells of a patient to target their tumour. Early findings from an 11-year study involving more than 300 people worldwide shows that those given the vaccine were living longer than expected, according to a paper published in the Journal of Translational Medicine.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 29, 2018 Category: Science Authors: Press Association Tags: Cancer Cancer research Health Medical research Science Society UK news US news World news Pharmaceuticals industry Business Source Type: news

New vaccine may keep patients alive 7 YEARS longer with the same cancer that killed Tessa Jowell
Scientists tested the DCVax-L injection, a form of immunotherapy, on more than 300 patients from the UK, US, Canada and Germany diagnosed with a glioblastoma. (Source: the Mail online | Health)
Source: the Mail online | Health - May 29, 2018 Category: Consumer Health News Source Type: news

Vaccine for cancer that killed Tessa Jowell 'remarkably promising'
A treatment for the cancer that killed Tessa Jowell could help to extend lives, a trial suggests. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 29, 2018 Category: Consumer Health News Source Type: news

No Link Between HPV Vaccine, Autoimmune Diseases: Study
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - May 29, 2018 Category: Cancer & Oncology Source Type: news

Tanzania:Over 5000 Girls Vaccinated for Cervical Cancer
[Daily News] MORE than 5000 girls in Dar es Salaam region have been vaccinated against cervical cancer since the vaccination campaign rolled out last April. The number is part of the targeted 24,097 girls to be reached in the fight against Human Papiloma Virus (HPV) which causes the disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 28, 2018 Category: African Health Source Type: news

DNA-based vaccine treatment for colorectal cancer to undergo first human study
(Digestive Disease Week) Combining a DNA vaccine, which boosts the body's immune response against tumors, with an antibody that blocks the body's natural defense against the potency of the DNA vaccine, may lead to the development of an effective treatment for late stage colorectal cancer, when a cure is not often possible. Preliminary research leading up to this trial will be presented at Digestive Disease Week ® 2018. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 22, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: Could Viagra and a flu shot kill cancer?
A Viagra, Cialis, and inactivated flu vaccine combination reduced cancer spread in a mouse model of post-surgery metastasis by helping the immune system. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 21, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

A mix of Viagra and the flu vaccine could treat cancer
The team at the University of Ottawa found that erectile dysfunction drugs block suppressor cells, allowing natural killer cells to do their cancer-fighting job. The flu vaccine further invigorates the killer cells. (Source: the Mail online | Health)
Source: the Mail online | Health - May 18, 2018 Category: Consumer Health News Source Type: news

Good Evidence That HPV Vaccines Protect Against Cervical Precancer
THURSDAY, May 17, 2018 -- Human papillomavirus (HPV) vaccines protect against cervical precancer in adolescent girls and young women, according to a review published online May 9 in the Cochrane Library. Marc Arbyn, M.D., from the Belgian Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2018 Category: Pharmaceuticals Source Type: news

ONCOS-102 Mesothelioma Trial Moves Forward
Oncologists in Spain are recruiting patients for the randomized phase of the pleural mesothelioma clinical trial involving ONCOS-102, the promising immunotherapy vaccine. Optimism surrounding the trial stems from encouraging results obtained recently in the six-patient safety cohort used as a precautionary lead-in. The trial involves the vaccine in combination with standard-of-care chemotherapy for patients with inoperable disease. ONCOS-102 is a scientifically engineered adenovirus that is designed to activate a patient’s immune system to selectively target cancer cells. It is being developed by Targovax, a Scandina...
Source: Asbestos and Mesothelioma News - May 17, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Sex, viruses and cancer
(The Ottawa Hospital) A new study suggests that a common treatment for erectile dysfunction combined with the flu vaccine may be able to help the immune system mop up cancer cells left behind after surgery. The study, published in OncoImmunology, shows that this unconventional strategy can reduce the spread of cancer by more than 90 percent in a mouse model. It is now being evaluated in a world-first clinical trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 17, 2018 Category: International Medicine & Public Health Source Type: news

Multi-epitope T-cell Vaccine Shows Promise in Ovarian, Breast Cancer
TPIV200 stimulates T cells to attack ovarian and triple negative breast tumor cells that over-express the folate receptor alpha protein. (Source: CancerNetwork)
Source: CancerNetwork - May 16, 2018 Category: Cancer & Oncology Authors: By John Schieszer Tags: Breast Cancer Immuno Oncology News Ovarian Cancer Source Type: news

Zimbabwe:Govt Rolls Out Anti-Cancer Vaccine in Schools
[The Herald] Government yesterday began the national roll-out of anti-cancer vaccine to girls between the ages of 10 and 14 years with a sizable number of girls agreeing to receiving the treatment in Harare. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 15, 2018 Category: African Health Source Type: news

Potential Role for Vaccines, Checkpoint Inhibitors in Chemoprevention of Lynch Syndrome
Researchers from MD Anderson say their study results " open the field of immunoprevention in LS to checkpoint inhibitors as an immune interception strategy. " (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Gastrointestinal Cancer News Source Type: news

Immunizing Cancer Patients: Which Patients? Which Vaccines? When to Give?
This article provides guidance to oncology clinicians on vaccine recommendations and safety of use in their patients. (Source: CancerNetwork)
Source: CancerNetwork - May 11, 2018 Category: Cancer & Oncology Authors: A Source Type: news

FDA Lays the Smackdown on Illegal Stem Cell Clinics
FDA is cracking down on stem cell clinics that market unapproved products and don't meet good manufacturing practice requirements. On behalf of the agency, the Department of Justice filed two complaints in federal court this week seeking permanent injunctions against a Florida-based clinic and a California-based clinic.  “Cell-based regenerative medicine holds significant medical opportunity, but we’ve also seen some bad actors leverage the scientific promise of this field to peddle unapproved treatments that put patients’ health at risk. In some instances, patients have suffered serious and per...
Source: MDDI - May 10, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

HPV jab safe and effective, study finds
Trials show the vaccine is low risk and protects girls and young women against a virus linked to cervical cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 9, 2018 Category: Consumer Health News Source Type: news

Media coverage of new Cochrane Review on HPV vaccine for cervical cancer prevention in girls and women
New evidencepublished today in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarizes findings on harms that have been assessed in randomized controlled trials. Below is a round-up for some of the media coverage.  " HPV vaccines prevent cervical cancer, global review confirms " on CNN" HPV jab safe and effective, studies finds "on BBC Health" Major review backs cervica cancer shots, especially for teens " on Business Insider" Does H...
Source: Cochrane News and Events - May 9, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Major review backs cervical cancer shots, especially for teens
(Reuters) - Vaccines designed to prevent infection with human papillomavirus (HPV) are effective in protecting against pre-cancerous cervical lesions in women, particularly in those vaccinated between age 15 and 26, according to a large international evidence review. (Source: Reuters: Health)
Source: Reuters: Health - May 9, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

HPV vaccines prevent cervical cancer, global review confirms
The human papillomavirus or HPV spreads through intimate contact during sex with someone who is infected. In some women, an HPV infection will persist and lead to cervical cancer. HPV vaccines protect against cervical cancer in young women, especially when the women are vaccinated between the ages of 15 and 26, a new Cochrane Report finds. (Source: CNN.com - Health)
Source: CNN.com - Health - May 9, 2018 Category: Consumer Health News Source Type: news

Major study confirms HPV vaccines prevent cervical cancer
The human papillomavirus or HPV spreads through intimate contact during sex with someone who is infected. In some women, an HPV infection will persist and lead to cervical cancer. HPV vaccines protect against cervical cancer in young women, especially when the women are vaccinated between the ages of 15 and 26, a new Cochrane Report finds. (Source: CNN.com - Health)
Source: CNN.com - Health - May 9, 2018 Category: Consumer Health News Source Type: news

Scientific expert reaction to new Cochrane Review on HPV vaccine for cervical cancer prevention in girls and women
This study looks at a collection of studies looking at the benefit of HPV vaccines in reducing pre cervical cancer lesions.  HPV also causes many other serious cancers (especially head and neck).  In time, as more people have been vaccinated, we will see a reduction in all HPV cancers.  The HP V vaccine is one of a number of vaccines using virus like particles (VLPS) which have been shown to be very safe over the last 35 years. “The Cochrane library of reviews has a very rigorous assessment process of all their reviews. “The review only looked at cervical precancer (in women and girls),...
Source: Cochrane News and Events - May 8, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Does HPV vaccination prevent the development of cervical cancer?
(Wiley) New evidence published today in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarizes findings on harms that have been assessed in randomized controlled trials. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 8, 2018 Category: International Medicine & Public Health Source Type: news

Does HPV vaccination prevent the development of cervical cancer? Are there harms associated with being vaccinated?
New evidence published today in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarizes findings on harms that have been assessed in randomized controlled trials.Most people who have sexual contact at some point in their life will be exposed to the human papilloma virus (HPV). In the majority of women, HPV infection will be cleared by the immune system. When the immune system does not clear the virus, persistent HPV infection can cause abnormal cervical cells. These lesion...
Source: Cochrane News and Events - May 7, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Biotech unicorn Moderna raises another $125M from partner Merck
Just three months after raising $500 million from a group of investors, Cambridge-based biotech unicorn Moderna Therapeutics has secured another $125 million from Merck& Co. Inc. under an existing cancer vaccine collaboration. Moderna, which is currently valued at around $7 billion, announced the deal with Merck (NYSE: MRK) on Thursday. Since 2016, the companies have been developing cancer treatments that combine Merck’s blockbuster drug Keytruda with Moderna’s “messenger RNA” vaccines,… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 4, 2018 Category: Health Management Authors: Max Stendahl Source Type: news

Merck Teams With Moderna To Take On One Of The Toughest Targets In Cancer
Merck is making a $125 million investment in Moderna as part of a new funding round. " We're encouraged by the potential for RNA-based vaccines, " says Eric Rubin, a Merck vice president. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 3, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:MRK NASDAQ:ABUS Source Type: news

Tanzania:Politicians Criticized for Holding Syringes to Vaccinate Girls, Defended
[Citizen] Dodoma -Minister for health Ummy Mwalimu has defended two politicians, whose photos showing them injecting cervical cancer vaccines to girls went viral, just a day after she condemned them through social media platforms. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 3, 2018 Category: African Health Source Type: news

MP calls for 'Tinder generation' boys to be vaccinated against HPV
Boys  should also be vaccinated against the human papilloma virus to protect against cancer, an MP says. (Source: the Mail online | Health)
Source: the Mail online | Health - May 3, 2018 Category: Consumer Health News Source Type: news

MP calls for boys from 'the Tinder generation' to be vaccinated against the human papilloma virus
Boys  should also be vaccinated against the human papilloma virus to protect against cancer, an MP says. (Source: the Mail online | Health)
Source: the Mail online | Health - May 3, 2018 Category: Consumer Health News Source Type: news

Novel cancer vaccine strategy blocks death of tumor-specific cytotoxic T cells
(Medical College of Georgia at Augusta University) A novel cancer vaccine strategy blocks death of tumor-specific cytotoxic T cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 1, 2018 Category: Biology Source Type: news

Innovative vaccine offers canine cancer patients a shot at a longer, happier life
(University of Pennsylvania) Nicola Mason of the School of Veterinary Medicine is leading a multi-institutional clinical trial evaluating an immunotherapy approach to treat dogs with osteosarcoma, a cancer of the bone. A new $775,000 grant from the Morris Animal Foundation will help her build on her past successes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2018 Category: Cancer & Oncology Source Type: news

Ethiopia:Ministry to Start Providing Vaccination Against Cervical Cancer in October This Year
[ENA] Ethiopia will start providing nationwide vaccination against cervical cancer beginning October 2018, Ministry of Health disclosed. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 25, 2018 Category: African Health Source Type: news

Tanzania:Allow Your Daughters to Get the HPV Vaccine
[Citizen] For a quite some time now, I have looked at cancer fighting strategies in Tanzania and realized that we still have a huge mountain to climb. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 24, 2018 Category: African Health Source Type: news